Longeveron Announces Additional Analysis For Phase 2a Clinical Trial Of Mild Alzheimer's Disease Stem Cell Therapy Laromestrocel Accepted For Poster Presentation At 2026 AAIC July 12-15
Longeveron Inc LGVN
$0.82
▼ -2.37%
($-0.02)
Open
$0.84
Prev Close
$0.84
Day Range
$0.82 – $0.87
52W Range
$0.48 – $1.80
Market Cap
$25.94M
Beta
-0.34
EPS (TTM)
$-1.17
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-02-12 |
| Shares Out. | 31,600,000 |
| Website | longeveron.com/ ↗ |
| Phone | 13053027158 |
Longeveron Inc is a publicly traded company under the ticker symbol LGVN on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-06-01)